News & Updates

AdvaMed announces partnership with USAID to strengthen global COVID-19 response

As part of the medtech industry’s ongoing mobilization to combat COVID-19, the Advanced Medical Technology Association (AdvaMed) today announced that the U.S. Agency for International Development (USAID) has approved a multi-year partnership under which the association will provide private sector resources and expertise to help increase adoption of medical technology-specific international regulatory standards and good regulatory practices by governments across Latin America, Africa, and Southeast Asia.

“The more similar laws and regulations are from country to country around the world, the better off patients will be. Expanding adoption of strong international standards and effective, common regulatory practice makes it easier and more efficient to get lifesaving medical technologies to the patients and providers who need them wherever they are in the world,” said Scott Whitaker, AdvaMed president and CEO. “This is even more important in the middle of a global fight against COVID-19 that requires cooperation across borders.”

“The initiative will facilitate public-private sector cooperation, trade and U.S. medtech exports, including access to COVID-19 tests, personal protective equipment and other essential supplies to fight the pandemic,” added Ralph Ives, AdvaMed executive vice president, global strategy and analysis. “This will help get the latest advances into the hands of health care providers on the front lines of the global health emergency.”

Under the partnership, AdvaMed will provide direct contributions for training, as well as staff time and technical expertise, aimed at increasing regulatory “convergence” across Latin America, Africa, and Southeast Asia through 2023. The project is part of a matching grant program, with USAID providing funds matching AdvaMed and partner contributions dollar for dollar up to $3 million. To date, USAID has committed over $1 billion to help fight the coronavirus pandemic.

The partnership is conducted with the American National Standards Institute (ANSI) under the USAID Standards Alliance Initiative to address COVID-19 response and recovery, and advance good regulatory practices for medtech, as part of the groups’ broader efforts to increase adoption of international standards for regulatory purposes. It builds on AdvaMed’s existing partnership with ANSI to promote good regulatory practices for medtech and lower trade barriers in Latin America, and the launch earlier this year of the Inter-American Coalition for Regulatory Convergence for the Medical Technology Sector.